Latest Breaking News On - Hanmi pharmaceutical - Page 2 : comparemela.com

Roche s R&D rethink hits 20% of molecules as cancer drugs axed

Roche s R&D rethink hits 20% of molecules as cancer drugs axed
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

South koreaThomas schineckerRoche genentechHanmi pharmaceuticalRepare therapeutics

THIRTEEN new Ozempic-like drugs are coming in the next few years as part of weight-loss goldrush

Drugmakers like Novo Nordisk and Amgen are capitalizing on the success of groundbreaking obesity drugs with plans to release an additional 13 treatments in the coming years.

South koreaSouth koreanNovo cagrisemaInnovent biologicsEli lillyJasper morleyBoehringer ingelheimNovo nordiskHanmi pharmaceuticalGerman based boehringer ingelheimViking therapeuticStructure therapeuticWeight loss

13 new obesity drugs could hit the market by 2029 amid surging demand (NYSE:NVO)

13 new obesity drugs could hit the market by 2029 amid surging demand (NYSE:NVO)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

South koreaSouth koreanJasper morleyInnovent biologicsEli lillyWorld health organizationNovo nordiskBoehringer ingelheimMedical doctorHanmi pharmaceuticalViking therapeuticStructure therapeutic

LG s ruling family loses bid to reduce 50% inheritance-tax bill

A Seoul rejected an attempt by the Koo family to recoup a sliver of their roughly $735 million payment.

Soult ukpyolsiSouth koreaUnited statesSouth koreanJiyoung sohnLee kun heeKim kyeong junTax foundationLg corpOrganization for economic cooperationSeoul administrative courtSamsung electronicsEconomic cooperationHanmi pharmaceutical

Double Life of Key Immune Protein Reveals New Strategies for Treating Cancer

A new study uncovers how targeting a specific immune cell surface receptor, PD-1, can enhance the effectiveness of cancer treatments by limiting its activity. Additionally, these insights lend support to emerging treatment approaches for autoimmune diseases conditions where the immune system mistake

Elliot philipsJun wangXiang peng kongRuimin panJia liuIanm ahearnYong zhouElliota philipsAudun kvalvaagAntonio garcia espaMichaell dustinAlexander leithnerKadam morAnnas tochevaHong liangDanr littman